AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors

Author：                

Publisher： Spandidos Publications

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.40, Iss.3, 2012-01, pp. : 876-888

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gastroenteropancreatic neuroendocrine tumors. Where are we now?

By Castellano Daniel  

Cancer and Metastasis Reviews, Vol. 30, Iss. 1, 2011-03 ,pp. : 1-1

Springer Publishing Company

Access to resources Recommend Favorite

Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center

By Yildiz Ozcan  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1050-1056

Humana Press, Inc

Access to resources Recommend Favorite

Prognostic impact of p16 and p21 on gastroenteropancreatic neuroendocrine tumors

By                  

Oncology Letters, Vol. 6, Iss. 6, 2013-01 ,pp. : 1641-1645

Spandidos Publications

Access to resources Recommend Favorite

Compound gastroenteropancreatic neuroendocrine and gastrointestinal stromal tumors in the stomach: A case report

By      

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 2996-2998

Spandidos Publications

Access to resources Recommend Favorite

Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors

By                  

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1659-1667

Spandidos Publications

Access to resources Recommend Favorite